Spruce Biosciences Inc (NAS:SPRB)
$ 0.4037 0.0082 (2.07%) Market Cap: 16.34 Mil Enterprise Value: -40.49 Mil PE Ratio: 0 PB Ratio: 0.32 GF Score: 32/100

Spruce Biosciences Inc at JMP Securities Life Sciences Conference Transcript

Jun 16, 2022 / 03:30PM GMT
Release Date Price: $1.46 (-8.75%)
Jon Wolleben
JMP Securities LLC - Analyst

Good morning, everybody. My name is Jon Wolleben, senior analyst here at JMP. And pleased to have Spruce Biosciences joining us for a talk. We've got CEO -- recently minted CEO, Javier Szwarcberg. Close?

Javier Szwarcberg
Spruce Biosciences, Inc. - CEO

Close enough.

Jon Wolleben
JMP Securities LLC - Analyst

Close enough. Well, thank you for coming, Javier.

Javier Szwarcberg
Spruce Biosciences, Inc. - CEO

My pleasure.

Questions & Answers

Jon Wolleben
JMP Securities LLC - Analyst

And for those who aren't as familiar with Spruce, this is a company we've been digging into for a little bit of time now. But tell us what you guys are working on.

Javier Szwarcberg
Spruce Biosciences, Inc. - CEO

So, we're working on a compound that inhibits the CRF1 receptor. It's an antagonist of receptor targeting two disease states, one is CAH,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot